9:22 AM
Leo Group India
| ||
| ||
| Pfizer To Acquire NextWave Pharmaceuticals, Inc. DailyFinance NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYS: PFE) today announced its intention to acquire NextWave Pharmaceuticals, a privately held, specialty pharmaceutical company focused on the development and commercialization of unique products for the ... See all stories on this topic » | ||
| Kinex Pharmaceuticals Closes First Tranche of Current Round Financing Sacramento Bee "Kinex has successfully evolved into an Oncology Specialty Pharmaceuticals company. The strategic positioning of the company over the past 18 months, through a number of transactions with key Asian Pharmaceutical partners, has enhanced Kinex's strong ... See all stories on this topic » | ||
| PHASE IIa LAQUINIMOD TRIAL RESULTS SHOW POSITIVE DATA FOR ... Reuters Jerusalem, Israel and Lund, Sweden, October 22, 2012 - Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) and Active Biotech (NASDAQ OMX NORDIC: ACTI) today announced the presentation of Phase IIa clinical data for investigational laquinimod in ... See all stories on this topic » | ||
| WATSON PHARMACEUTICALS, INC. : Watson to Host Third Quarter 2012 ... 4-traders PARSIPPANY, N.J., Oct. 22, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced that the Company intends to release its third quarter 2012 financial results on November 1, 2012, ... See all stories on this topic » | ||
| ||
| Is Teva Pharmaceutical Industries A Good Stock to Buy? Insider Monkey (blog) teva-pharmaceuticals Teva Pharmaceutical Industries Ltd (NYSE:TEVA)'s business has been doing well so far in 2012. In the first half of the year, revenue was up 22% versus the same period in 2011, including a 19% increase in the second quarter. See all stories on this topic » | ||
| Hikma Pharmaceuticals sign marketing deal Stock Market Wire StockMarketWire.com - Hikma Pharmaceuticals has signed a licence and supply agreement for the registration and marketing of Lutrate® 1 month, GP Pharm's leading anti-cancer compound, for the Middle East and North Africa ("MENA") region. Lutrate® 1 ... See all stories on this topic » | ||
| Sun Pharmaceutical Industries to announce Q2 results on Nov 08, 2012 Equity Bulls A Meeting of the Board of Directors of Sun Pharmaceutical Industries Ltd will be held on November 08, 2012, to consider and take on record the un-audited financial results of the Company for the second quarter / half year ended September 30, 2012. The ... See all stories on this topic » | ||
| CHINA PHARMACEUTICAL : Poll Results of the Extraordinary General Meeting ... 4-traders References are made to the announcement of China Pharmaceutical Group Limited (the "Company") dated June 26, 2012 and the circular of the Company dated September 27, 2012 (the " Circular") in relation to, among other things, the Acquisition and the ... See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment